Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Simvastatin in acute optic neuritis.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Natalizumab to fingolimod washout in patients at risk of PML: When good intentions yield bad outcomes.
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
Optical coherence tomography in multiple sclerosis.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Segway use in individuals with multiple sclerosis.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
MARINOL®
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Brain Region-specific Alterations in the Gene Expression of Cytokines, Immune Cell Markers and Cholinergic System Components During Peripheral Endotoxin-induced Inflammation.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
MSer – A new, neutral descriptor for someone with multiple sclerosis
Genetics of primary progressive multiple sclerosis.
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Analysis of the Paired TCR α- and β-chains of Single Human T Cells.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
France Banned AB Science Drug Studies Because of Side Effects

Pages